BR112013016546A2 - processo para aperfeiçoamento de rilpivirina - Google Patents

processo para aperfeiçoamento de rilpivirina

Info

Publication number
BR112013016546A2
BR112013016546A2 BR112013016546A BR112013016546A BR112013016546A2 BR 112013016546 A2 BR112013016546 A2 BR 112013016546A2 BR 112013016546 A BR112013016546 A BR 112013016546A BR 112013016546 A BR112013016546 A BR 112013016546A BR 112013016546 A2 BR112013016546 A2 BR 112013016546A2
Authority
BR
Brazil
Prior art keywords
rilpivirine
hydrochloride
isomer
less
improvement
Prior art date
Application number
BR112013016546A
Other languages
English (en)
Inventor
Badhe Sachin Aravind
Gurjar Mukund Keshav
Joshi Shashikant Gangaram
Maikap Golakchandra Sudarshan
Mehta Samit Satish
Original Assignee
Emcure Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emcure Pharmaceuticals Ltd filed Critical Emcure Pharmaceuticals Ltd
Publication of BR112013016546A2 publication Critical patent/BR112013016546A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/04—Preparation of carboxylic acid nitriles by reaction of cyanogen halides, e.g. ClCN, with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/34—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by unsaturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

processo para aperfeiçoamento da rilpivirina. a presente invenção refere-se à preparação de um intermediário chave de rilpivirina, a saber, o cloridrato de (e)-4-(2-cianoetenil)-2,6-dimetilfenilamina (ll), por um processo que compreende a reação do sal de diazônio tetrafluoroborato do composto 2,6-dimetil-4-amino-1-carboxibenzil fenilamina (vi) com acrilonitrila na presença de acetato de paládio, seguido pelo tratamento com um ácido e a sua subsequente conversão no sal cloridrato (ll), caracterizado por o isômero z indesejado ser inferior a 0,5%, e proporcionar o cloridrato de rilpivirina com isômero z inferior a 0,1%.
BR112013016546A 2011-04-15 2012-04-09 processo para aperfeiçoamento de rilpivirina BR112013016546A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1223MU2011 2011-04-15
PCT/IN2012/000246 WO2012143937A2 (en) 2011-04-15 2012-04-09 An improved rilpivirine process

Publications (1)

Publication Number Publication Date
BR112013016546A2 true BR112013016546A2 (pt) 2016-09-27

Family

ID=47041983

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013016546A BR112013016546A2 (pt) 2011-04-15 2012-04-09 processo para aperfeiçoamento de rilpivirina

Country Status (10)

Country Link
US (1) US8952155B2 (pt)
EP (1) EP2643294B1 (pt)
JP (1) JP5870183B2 (pt)
KR (1) KR101879468B1 (pt)
AP (1) AP2013006779A0 (pt)
BR (1) BR112013016546A2 (pt)
EA (1) EA024409B1 (pt)
ES (1) ES2604405T3 (pt)
WO (1) WO2012143937A2 (pt)
ZA (1) ZA201302020B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2848631C (en) * 2011-09-16 2019-10-01 Hetero Research Foundation Rilpivirine hydrochloride
WO2013153162A1 (en) * 2012-04-11 2013-10-17 Sandoz Ag Polymorph of rilpivirine hydrochloride
WO2013153161A2 (en) * 2012-04-11 2013-10-17 Sandoz Ag Novel polymorph of rilpivirine hydrochloride
CZ201532A3 (cs) * 2015-01-21 2015-02-25 Zentiva, K.S. Způsob výroby vysoce čistého Rilpivirinu a jeho solí
CN107162987A (zh) * 2016-03-07 2017-09-15 宜昌人福药业有限责任公司 一种利匹韦林的工业化合成方法及中间体化合物
WO2020084142A1 (en) 2018-10-25 2020-04-30 Minakem Process for the preparation of rilpivirine
CN112778214A (zh) * 2021-01-13 2021-05-11 安徽贝克联合制药有限公司 用于合成利匹韦林的中间体、其合成方法和利匹韦林的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
ES2422196T3 (es) * 2002-08-09 2013-09-09 Janssen Pharmaceutica Nv Procesos para la preparación de 4-4-4-(2-cianoetenil)-2,6-dimetilfenil)amino)-2-pirimidinil)aminobenzonitrilo
EP1632232B3 (en) * 2004-09-02 2022-03-30 Janssen Pharmaceutica NV Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile

Also Published As

Publication number Publication date
KR20130143046A (ko) 2013-12-30
ES2604405T3 (es) 2017-03-06
JP2014522385A (ja) 2014-09-04
US8952155B2 (en) 2015-02-10
WO2012143937A3 (en) 2013-03-21
ZA201302020B (en) 2014-05-28
WO2012143937A2 (en) 2012-10-26
EA024409B1 (ru) 2016-09-30
AP2013006779A0 (en) 2013-03-31
KR101879468B1 (ko) 2018-07-17
EP2643294A4 (en) 2014-12-24
US20140275538A1 (en) 2014-09-18
JP5870183B2 (ja) 2016-02-24
EP2643294A2 (en) 2013-10-02
EA201301170A1 (ru) 2014-02-28
EP2643294B1 (en) 2016-08-24

Similar Documents

Publication Publication Date Title
BR112013016546A2 (pt) processo para aperfeiçoamento de rilpivirina
BRPI1011506B8 (pt) processo para a fabricação de moduladores de regulador de condutância de transmembrana de fibrose cística
BR112013018975A2 (pt) processo para o preparo de 4-amino-5-fluoro-3-halo-6-(substituído)picolinatos
BR112014009790A2 (pt) composto para modulação antisense da expressão de gccr, seu uso e composição
BR112015031913A2 (pt) processo para a fabricação de amino-benzoxazinonas 4-propargilatadas e sua utilização
BR112015007243A2 (pt) processo melhorado para fabricação de 5-(2,6-di-4-morfolinil-4-pirimidinil)-4-trifluorometilpiridin-2-amina
BR112014004210A2 (pt) processo para a preparação de derivados de diamida do ácido antranílico substituídos com tetrazole por reação de benzoxazinonas com aminas
BR112014018756A8 (pt) Processo para preparo de etil éster de ácido n-(4-ciclo-hexil-3-trifluorometil-benziloxi)-acetimídico
BR112013018942A8 (pt) Processo para o preparo de 4-amino-3-cloro-5-fluro-6(substituído)-picolinatos
BR112014006587A2 (pt) modulação antisense da expressão de gcgr
BR112012011961A2 (pt) processo para produzir cloretos de ácido 5-flúor-1-alquil-3-fluoralquil-1h-pirazol-4-carboxílico
BR112015025543A2 (pt) processo para a preparação de (3r,4r)-(l-benzil-4-metilpiperidina-3-il)- metilamina e compostos
CO6420351A2 (es) Composiciones plaguicidas
BRPI0918580B8 (pt) polimorfo cristalino b da n-(2-aminofenil)-4-[n-(piridina3-il)metóxi-carbonilaminometil]-benzamida, composição e combinação contendo o mesmo, uso e seu processo de produção
BR112013026660A2 (pt) métodos ou processos para produção de depsipeptídeos macrocíclicos e intermediários
WO2012161538A3 (ko) 형질전환 예쁜꼬마선충 및 이를 이용하여 당 대사 조절물질을 검색하는 방법
BRPI0518487A2 (pt) carboxamidas e seu uso
BR112013023880A2 (pt) vidro plano e processo para produzir o mesmo
BR112012031395A2 (pt) revestimento sol-gel resistente à corrosão e composição e processo para sua fabricação
BR112014018909A8 (pt) Compostos, processo para a preparação dos compostos, composição agroquímica, método para o combate dos fungos, utilização dos compostos e semente
MX347075B (es) Colorantes acidos de trisazo.
PE20121473A1 (es) Uso de 4-[etil(dimetil)amonio]butanoato en el tratamiento de enfermedades cardiovasculares
BR112015024859A2 (pt) processo e intermediários para a preparação de pregabalina
BR112015015229A8 (pt) processo para a preparação de um composto da fórmula, e, composto
BR112015007821A2 (pt) processo para a preparação de voriconazol e análogos do mesmo

Legal Events

Date Code Title Description
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]